TD Asset Management
RCUS icon

TD Asset Management’s Arcus Biosciences RCUS Stock Holding History

TD Asset Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$610K Buy
+19,774
New +$489K ﹤0.01% 1158
2023
Q3 		– Sell
-23,500
Closed -$477K – 1441
2023
Q2 		$477K Buy
23,500
+8,100
+53% +$154K ﹤0.01% 1276
2023
Q1 		$281K Sell
15,400
-46,900
-75% -$896K ﹤0.01% 1348
2022
Q4 		$1.29M Buy
+62,300
New +$1.71M ﹤0.01% 1097
2019
Q1 		– Sell
-20,758
Closed -$224K – 1385
2018
Q4 		$224K Sell
20,758
-2,003
-9% -$23.4K ﹤0.01% 1342
2018
Q3 		$317K Sell
22,761
-6,497
-22% -$82.9K ﹤0.01% 1362
2018
Q2 		$358K Hold
29,258
– – ﹤0.01% 1334
2018
Q1 		$452K Buy
+29,258
New +$487K ﹤0.01% 1223

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

TD Asset Management's RCUS Position: Q2 2026 in Review

TD Asset Management opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 19,774 shares worth $610K. The stake represents ﹤0.01% of the portfolio and ranks #1158 among its holdings. This is a return to the name: TD Asset Management previously reported a position in RCUS as recently as Q2 2023.

TD Asset Management first reported a position in RCUS in Q1 2018 and has held it in 8 quarters since. The position peaked at $1.29M in Q4 2022. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • TD Asset Management held 19,774 shares of Arcus Biosciences worth $610K as of Q2 2026.
  • Arcus Biosciences was a new TD Asset Management position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1158 holding.
  • TD Asset Management first reported a position in Arcus Biosciences in Q1 2018 and has held it in 8 quarters since.
  • TD Asset Management's Arcus Biosciences position peaked at $1.29M in Q4 2022.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.